Evidence map›Paper›PMID 39407697›Full record

ReviewMolecules (Basel, Switzerland)2024

Indole Derivatives: A Versatile Scaffold in Modern Drug Discovery-An Updated Review on Their Multifaceted Therapeutic Applications (2020-2024).

Xingyou Mo, Devendra Pratap Rao, Kirandeep Kaur, Roket Hassan, Ahmed S Abdel-Samea, Sara Mahmoud Farhan, Stefan Bräse, Hamada Hashem

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 35 papers.

0numbers the graph read from it
0cells of the map it votes in
35citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

35 citing papers in PubMed.

  1. Synthetic strategies and therapeutic insights into FDA-approved indole-containing drugs.Journal of enzyme inhibition and medicinal chemistry · 2026
    Review
  2. Sequence Inversion Dictates the Antiproliferative Activity of Bidirectional Tryptophan-Containing Dipeptide Libraries.Journal of peptide science : an official publication of the European Peptide Society · 2026
    Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. C(spMedicinal chemistry research : an international journal for rapid communications on design and mechanisms of action of biologically active agents · 2026
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Crystal structure and Hirshfeld surface analysis of 3,3'-(sulfanedi-yl)bis-(2-iodo-1-methyl-1Acta crystallographica. Section E, Crystallographic communications · 2026
    Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Review
  18. Molecular Pharmacology at the Crossroads of Precision Medicine.Current issues in molecular biology · 2025
    Article
  19. Review
  20. Antifungal Activities of Multi-Halogenated Indoles Against Drug-ResistantInternational journal of molecular sciences · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xingyou MoSchool of Engineering, Guangzhou College of Technology and Business, Guangzhou 510850, China.
Devendra Pratap RaoCoordination Chemistry Laboratory, Department of Chemistry, Dayanand Anglo-Vedic (PG) College, Kanpur 208001, Uttar Pradesh, India.ORCID 0000-0003-4628-9121
Kirandeep KaurDepartment of Chemistry, Maharaja Ranjit Singh Punjab Technical University, Bathinda 151001, Punjab, India.
Roket HassanDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University, Sohag 82524, Egypt.
Ahmed S Abdel-SameaPharmacology & Toxicology Department, Faculty of Pharmacy, Deraya University, New Minia 61768, Egypt.
Sara Mahmoud FarhanDepartment of Microbiology and Immunology, Faculty of Pharmacy, Deraya University, New Minia 61768, Egypt.ORCID 0000-0002-7857-2020
Stefan BräseInstitute of Biological and Chemical Systems-Functional Molecular Systems (IBCS-FMS), Karlsruhe Institute of Technology (KIT), Kaiserstrasse 12, 76131 Karlsruhe, Germany.ORCID 0000-0003-4845-3191
Hamada HashemDepartment of Pharmaceutical Chemistry, Faculty of Pharmacy, Sohag University, Sohag 82524, Egypt.ORCID 0000-0002-8649-7534

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Indole derivatives have become an important class of compounds in medicinal chemistry, recognized for their wide-ranging biological activities and therapeutic potential. This review provides a comprehensive overview of recent advances in the evaluation of indole-based compounds in the last five years, highlighting their roles in cancer treatment, infectious disease management, anti-inflammatory therapies, metabolic disorder interventions, and neurodegenerative disease management. Indole derivatives have shown significant efficacy in targeting diverse biological pathways, making them valuable scaffolds in designing new drugs. Notably, these compounds have demonstrated the ability to combat drug-resistant cancer cells and pathogens, a significant breakthrough in the field, and offer promising therapeutic options for chronic diseases such as diabetes and hypertension. By summarizing recent key findings and exploring the underlying biological mechanisms, this review underscores the potential of indole derivatives in addressing major healthcare challenges, thereby instilling hope and optimism in the field of modern medicine.

Indexed as

Drug DiscoveryIndolesAnimalsAnti-Inflammatory AgentsAntineoplastic AgentsHumansMetabolic DiseasesNeoplasmsNeurodegenerative DiseasesAnti-Inflammatory AgentsAntineoplastic AgentsIndolesanticancerantidiabeticantihypertensiveanti-inflammatoryantimicrobialbiological activitiesindoleneurodegenerative diseases

Identifiers

PMID39407697
PMCPMC11477627

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.